Dermisonics, Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a DMSI research report →
Companywww.dermisonics.com
Dermisonics, Inc. manufactures ultrasonic transdermal drug-delivery technologies and equipment. It primarily focuses on the development, testing, and commercialization of its active transdermal patch, called the U-Strip, that has been designed to facilitate the needle-free delivery of drugs with large molecular structures, such as Insulin into the bloodstream.
- CEO
- Bruce H. Haglund
- IPO
- 2003
- HQ
- Irvine, CA, US
Price Chart
Valuation
- Market Cap
- $1.92K
- P/E
- -0.00
- P/S
- 0.00
- P/B
- 0.00
- EV/EBITDA
- -0.67
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- -32.40%
- ROIC
- 0.00%
Growth & Income
- Revenue
- $0 · 0.00%
- Net Income
- $-5,084,047 · 26.94%
- EPS
- $-0.12 · 29.41%
- Op Income
- $-4,488,275
- FCF YoY
- -6.04%
Performance & Tape
- 52W High
- $0.00
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- -244.38
- Avg Volume
- 435.2
Get TickerSpark's AI analysis on DMSI
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Mar 27, 06 | ATKINS GRANT R | other | 0 |
Our DMSI Coverage
We haven't published any research on DMSI yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate DMSI Report →